Krämer A,
Hübner G,
Schneeweiss A,
Folprecht G,
Neben K.
Carcinoma of Unknown Primary - an Orphan Disease? Breast Care (Basel),
2008;3:164-170
Pavlidis N et al.
Diagnostic and therapeutic management of cancer of unknown primary.
European Journal of Cancer 2003,
39:1990-2005
Pavlidis N et al.
Cancer of unknown orimary site.
Lancet 2012,
379:1428-35
Pentheroudakis G,
Lazaridis G,
Pavlidis N.
Axillary nodal metastases from
carcinoma of unknown primary (CUPAx): a systematic review of published evidence.
Breast Cancer Res Treat,
2010;119:1-11
Taylor MB,
Bromham NR,
Arnold SE.
Carcinoma of unknown primary: key
radiological issues from the recent National Institute for Health and Clinical
Excellence guidelines.
Br J Radiol,
2012;85:661-71
Zaun G et al.
CUP Syndrome – Metastatic Malignancy with Unknown Tumor.
Dtsch Arztebl Int 2018;115:157-62
Ouldamer L et al.
Axillary lymph node metastases from unknown primary: A French multicentre study.
Eur J Obst Gyn and Reprod Biol 2018,
223:103-107
Bresser J,
de Vos B,
van der Ent F,
Hulsewé K.
Breast MRI in clinically and
mammographically occult breast cancer presenting with an axillary metastasis: a systematic review.
Eur J Surg Oncol,2010 36:114-9
Sardanelli F,
Boetes C,
Borisch B,
Decker T,
Federico M,
Gilbert FJ,
Helbich
T,
Heywang-Köbrunner SH,
Kaiser WA,
Kerin MJ,
Mansel RE,
Marotti L,
Martincich Mauriac L,
Meijers-Heijboer H,
Orecchia R,
Panizza P,
Ponti A,
Purushotham AD,Regitnig P,
Del Turco MR,
Thibault F,
Wilson R.
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
Eur J Cancer ,2010 May:1296-316.
Heywang-Kobrunner SH et al.
Magnetic resonance imaging: the evolution of breast imaging.
Breast 2013,
22:S77-82
Kodaira M et al.
Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
BMC Cancer 2018,
18:176-185